Cargando…
Evaluation of using composite HPV genotyping assay results to monitor human papillomavirus infection burden through simulation
BACKGROUND: Researchers often group various HPV types into composite measures based on vaccine subtypes, oncogenic potential, or phylogenetic position. Composite prevalence estimates based on PCR genotyping assay results have been calculated to assess HPV infection burden and to monitor HPV vaccine...
Autor principal: | Lin, Carol Y |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362818/ https://www.ncbi.nlm.nih.gov/pubmed/25880688 http://dx.doi.org/10.1186/s12879-015-0851-x |
Ejemplares similares
-
An economical Nanopore sequencing assay for human papillomavirus (HPV) genotyping
por: Chan, Wai Sing, et al.
Publicado: (2020) -
Comparison of Seegene Anyplex II HPV28 assay with BD Onclarity HPV assay for human papillomavirus genotyping
por: Kim, Moonsik, et al.
Publicado: (2022) -
Comparison of DNA testing strategies in monitoring human papillomavirus infection prevalence through simulation
por: Lin, Carol Y., et al.
Publicado: (2016) -
Evaluation of the characteristics of multiple human papillomavirus (HPV) infections identified using the BD Onclarity HPV assay and comparison with those of single HPV infection
por: Kim, Jinhee, et al.
Publicado: (2022) -
Characterization of Novel Cutaneous Human Papillomavirus Genotypes HPV-150 and HPV-151
por: Kovanda, Anja, et al.
Publicado: (2011)